003850.KS
Boryung Pharm Co Ltd
Price:  
8,350 
KRW
Volume:  
98,854
Korea, Republic of | Pharmaceuticals

003850.KS WACC - Weighted Average Cost of Capital

The WACC of Boryung Pharm Co Ltd (003850.KS) is 7.2%.

The Cost of Equity of Boryung Pharm Co Ltd (003850.KS) is 8.1%.
The Cost of Debt of Boryung Pharm Co Ltd (003850.KS) is 4.25%.

RangeSelected
Cost of equity7.0% - 9.2%8.1%
Tax rate27.3% - 28.7%28%
Cost of debt4.0% - 4.5%4.25%
WACC6.2% - 8.1%7.2%
WACC

003850.KS WACC calculation

CategoryLowHigh
Long-term bond rate3.1%3.6%
Equity market risk premium5.8%6.8%
Adjusted beta0.670.75
Additional risk adjustments0.0%0.5%
Cost of equity7.0%9.2%
Tax rate27.3%28.7%
Debt/Equity ratio
0.230.23
Cost of debt4.0%4.5%
After-tax WACC6.2%8.1%
Selected WACC7.2%

003850.KS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for 003850.KS:

cost_of_equity (8.10%) = risk_free_rate (3.35%) + equity_risk_premium (6.30%) * adjusted_beta (0.67) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.